Canary Islands University Hospital Launches First Atopic Dermatitis School

The University Hospital Complex of the Canary Islands (HUC) has launched its first "Atopic Dermatitis School," marking a significant shift in how the region manages chronic skin conditions. Supported by the Canary Islands Health Research Institute Foundation (FIISC) and various biomedical partners, the initiative moves beyond standard clinical care to prioritize patient education as a vital part of treatment.

Atopic dermatitis is a common inflammatory condition, affecting one in five children and nearly 1.5 million people across Spain. Because the condition requires more than just a standard doctor’s visit, the hospital’s Dermatology Department hosted a special event to provide a more comprehensive approach to care. Specialists, including Dr. Marta García Bustínduy and Deputy Medical Director María José Sánchez, emphasized the importance of "humanizing" medicine. The program offered practical training on managing symptoms—such as itching—as well as proper hydration and medication techniques led by the nursing team.

A key feature of the program was the inclusion of mental health. Psychologist Jezabel Bravo discussed the emotional challenges faced by patients and their caregivers, an area often overlooked in traditional medical settings. This focus was supported by África de Luca Tena, president of the Association of People Affected by Atopic Dermatitis (AADA), who highlighted the importance of patient advocacy in these educational forums.

Backed by companies including AbbVie, Sanofi, Rilastil, and Ducray, this initiative aligns with international standards for managing atopic diseases. Since the condition often occurs in flare-ups and is frequently linked to asthma, food allergies, and hay fever, these training sessions are a necessary step toward reducing the burden on the healthcare system and improving long-term outcomes for patients in the Canary Islands.